Add BrightSurf on Google Email

Chinese Medical Journals Publishing House Co., Ltd.


Pre-eclampsia leaves a lasting impact by worsening stroke outcomes postpartum in rats

A study reveals that pre-eclampsia increases the risk of developing severe cerebrovascular complications, including stroke, after childbirth. The researchers found that a history of PE impairs collateral recruitment and worsens ischemic stroke outcomes due to increased sensitivity to cerebral ischemia and elevated oxidative stress.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeExperimental study·DateJun 6, 2025

Chinese Medical Journal article reviews classification, synthesis, and applications of ‘herbzymes’

Researchers review nanozymes derived from Chinese herbs, including their catalytic properties, biomedical applications, and potential challenges in developing herbzymes for practical use. The review highlights three main types of herbzymes: herb carbon dot enzymes, polyphenol-metal nanozymes, and herb extract nanozymes.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateJun 6, 2025

Chinese Medical Journal article reveals the anticancer potential of poly ADP-ribose polymerase inhibitors

PARP inhibitors have been found to be effective in treating cancers with BRCA1/2 mutations by blocking DNA repair pathways. The combination of PARPis with chemotherapeutic drugs can also improve treatment efficacy, increasing DNA damage and blocking repair processes.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateMar 4, 2025

Chinese Academy of Sciences explores the application of intelligent imaging technology

Researchers found AI-based imaging technology improves disease diagnosis accuracy, particularly in cardiology, oncology, neurology, and ophthalmology. The technology also enhances diagnostic efficiency and reduces healthcare disparities by delivering high-quality diagnostics to underserved areas.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateJan 23, 2025

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs

A study published in Chinese Medical Journal explores the use of artificial intelligence to identify potential medications for treating glaucoma. Researchers used AI models to predict the effectiveness of small-molecule compounds targeting RIPK3, a key signaling molecule involved in programmed cell death.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateJan 2, 2025

Chinese Medical Journal review discusses the future prospects of medical AI

A comprehensive analysis of medical AI technologies highlights their potential in improving diagnostic accuracy and customizing treatments. However, challenges such as data collection and analysis, biases, and patient privacy concerns need to be addressed through standardized evaluation protocols and effective collaborations.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateDec 20, 2024

Chinese Medical Journal review provides insights into respiratory syncytial virus

Researchers provide comprehensive review of RSV's virology, clinical impact, and prevention strategies, emphasizing the need for effective vaccines to mitigate this critical health need. The review highlights RSV's severe impact on infants, children, and older adults, as well as its potential effects on multiple organs and systems.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateDec 20, 2024

Chinese Medical Journal article sheds light on the global lifetime risk of lung cancer

The global lifetime risk of lung cancer is 3.49%, with high-risk countries like French New Caledonia and Canada, while low-HDI countries have lower risks due to shorter lifespans and limited resources. After 40, the risk drastically increases, but residual risk decreases with age.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateDec 4, 2024

Chinese Medical Journal study reveals key insights on the global burden of thyroid cancer in 2022

A study published in the Chinese Medical Journal projects a significant rise in global thyroid cancer burden, with 821,214 new cases and 47,507 related deaths reported worldwide in 2022. The incidence is expected to increase by 44.1% from 2019 to 2030, with women experiencing higher rates than men.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeObservational study·DateOct 16, 2024

Chinese Medical Journal investigates recent and future trends of lung cancer

According to the Global Cancer Observatory (GLOBOCAN), lung cancer is the most common type of cancer, with 2.2 million new cases and 1.8 million deaths worldwide in 2020. China had the highest number of new cases, and incidence and mortality rates have been steadily rising from 1990 to 2019.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateSep 26, 2024

Chinese Medical Journal review article explores cerebellar involvement in Parkinson's disease

Researchers comprehensively reviewed cerebellar involvement in Parkinson's disease, highlighting the pathophysiological role of the cerebellum in motor and non-motor symptoms. Studies showed abnormal α-synuclein aggregation, neurodegeneration, and altered functional connectivity between the cerebellum and other brain regions.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateSep 18, 2024

Chinese Medical Journal study provides updates on rising burden of breast cancer in China

The study examines breast cancer incidence, mortality, and disease burden in China to inform urgent prevention and treatment strategies. The Age-Standardized Incidence Rate is relatively low compared to other countries, but the sheer number of cases and DALYs highlights a significant public health challenge.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateSep 12, 2024

Chinese Medical Journal Pulmonary and Critical Care Medicine study explores nicotine dependence among smokers in China

A recent study published in the Chinese Medical Journal Pulmonary and Critical Care Medicine investigated nicotine dependence among smokers in China. The research found that 41.0% of smokers aged 40 and above had medium-to-high nicotine dependence, with men more affected than women.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal - Pulmonary and Critical Care Medicine·TypeSurvey·DateSep 11, 2024

New Chinese Medical Journal Pulmonary and Critical Care Medicine study provides key insights into pathogenesis mechanisms of lung fibrosis

A literature review examines key cell-cell interactions driving pulmonary fibrosis, revealing complex interplay between diverse lung cell types and intricate processes. The study highlights potential ligands involved in PF, including tumor necrosis factor, interleukin 1β, and ADAM17, and suggests targeting CCIs for novel therapies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal - Pulmonary and Critical Care Medicine·TypeLiterature review·DateSep 5, 2024

Chinese Medical Journal reports on emerging trends and implications of non-communicable diseases in China

Non-Communicable Diseases (NCDs) are a major global health issue, characterized by their chronic nature and long-term impact on quality of life. In China, understanding the extent and distribution of NCDs is essential for developing effective public health strategies.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateSep 4, 2024